Programmed cell death markers in COVID-19 survivors with and without sepsis
These findings provide insight into the molecular signatures distinguishing immune responses in COVID-19-related sepsis and may serve as valuable biomarkers for assessing disease severity, while guiding therapeutic interventions in critical care settings.
Authors
- Srinivasa Ikswaja Chelluri (ORCID: https://orcid.org/0000-0002-0408-6708)
- Chandra Shekar Mallarpu
- Maneendra Singarapu
- Charitha Madiraju (ORCID: https://orcid.org/0000-0002-7005-2418)
- Lakshmi Kiran Chelluri
- Tapaswi Krishna Katragadda
Institutions
- Marshall B. Ketchum University (US)
- Apollo Gleneagles Hospitals (IN)
- Center for Discovery (US)
- Bharati Vidyapeeth (Deemed to be University) (IN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-02-20
- DOI
- https://doi.org/10.3389/fimmu.2025.1535938
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00